final action
on 23 Dec 2024
Last Applicant/ Owned by
ATTN: General Counsel
Monmouth Junction
NJ
08852
Serial Number
98397270 filed on 08th Feb 2024
Registration Number
N/A
Correspondent Address
Cathy Kodroff
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Distributorship of prescription and non-prescription generic pharmaceutical medicines and preparations Prescription and non-prescription generic pharmaceutical medicines and preparations for the treatment of cold and allergy symptoms, respiratory disease, asthma and chronic lung disease, upper respiratory symptoms, coughs, diabetes, high cholesterol, high blood pressure, bacterial infections, mal Read More
Prescription and non-prescription generic pharmaceutical medicines and preparations for the treatment of cold and allergy symptoms, respiratory disease, asthma and chronic lung disease, upper respiratory symptoms, coughs, diabetes, high cholesterol, high blood pressure, bacterial infections, malaria, hyperuricemia, gout, central nervous system disorders, namely, narcolepsy and attention deficit hyperactivity disorder, for the treatment of autism, schizophrenia, bipolar disorder, convulsions, epilepsy, nausea, vomiting, pruritus, for inducing sedation, for pain relief, and for anti-inflammation
N/A
N/A
Distributorship of prescription and non-prescription generic pharmaceutical medicines and preparations
N/A
N/A
No 98397270
No Service Mark
No CP CRANBURY
No
No
No
No
No
No
No
No
26.09.21 -
Squares that are completely or partially shaded
Status Date | Action Taken |
---|---|
23rd Dec 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
23rd Dec 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
23rd Dec 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
25th Sep 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
25th Sep 2024 | NON-FINAL ACTION E-MAILED |
25th Sep 2024 | NON-FINAL ACTION WRITTEN |
24th Sep 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
24th Sep 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
24th Sep 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
03rd Sep 2024 | NON-FINAL ACTION E-MAILED |